Shares of Alpharetta, Georgia-based Inhibitex Inc.
(NASDAQ: INHX) have risen sharply in trading today after the company agreed to
be acquired by Bristol-Myers Squibb Co. (NYSE: BMY). Under the terms of the
definitive agreement, Bristol-Myers Squibb will acquire Inhibitex for $26 per
share in cash.
Inhibitex shares rose to a new 52-week high of
$24.08 in trading today, and at last check, the stock was up more than 140% on
above average volume. The rally has pushed Inhibitex shares above their 50-day
and 200-day moving averages.
To get more information on Inhibitex Inc. please
click here…
